This chart shows the companies with the successful drug patent challenges from last year. The most successful drug patent challengers […]
Who are the most successful drug patent challengers? Read Post »
I will be helping judge the AUTM Venture Forum again this year. The competition features a $10,000 prize for the
This guest post is from the BiotechBlog Intern, Fintan Burke. Fintan is a student at the School of Biotechnology at Dublin
Thinking Laterally: Examining the Flexible Career Path in Life Sciences Read Post »
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
A brave new Europe with the introduction of the EU Clinical Trials Directive: Impact upon the pharma industry and academic research with special emphasis on…
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Intellectual property: The driving force for growth and funding
Go to paperABSTRACT: For most ‘bio-entrepreneurs’ the science is the easy part — leveragin…
Intellectual property: The driving force for growth and funding Read Post »
Made available by the elective open access option at the Journal of Commercial Biotechnology, this paper is free to view without subscription: The
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Fostering the process of adoption of personalised medicine: A matter of communication or a matter of cost?
Go to paperABSTRACT: Pharmacogenetics, along with…
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post?
Biotechnology in Countries Starting with "I" – Part 4: Ireland Read Post »
This guest post is from the BiotechBlog Intern, Fintan Burke. Fintan is a student at the School of Biotechnology at Dublin
Crowdsourcing in the Biotech world: Innovation and outreach to a wider public Read Post »
In the last weeks, India has seen serious setbacks to its life sciences industry. The NIH recently announced that they